tiprankstipranks
LSL Pharma Group Inc (TSE:LSL)
TSXV:LSL
Canadian Market
Holding TSE:LSL?
Track your performance easily

LSL Pharma Group Inc (LSL) Financial Statements

0 Followers

LSL Pharma Group Inc Financial Overview

LSL Pharma Group Inc's market cap is currently ―. The company's EPS TTM is C$-0.023; its P/E ratio is -18.97; LSL Pharma Group Inc is scheduled to report earnings on November 27, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total RevenueC$ 4.19MC$ 4.16MC$ -2.51BC$ 2.51BC$ 2.03M
Gross ProfitC$ 1.54MC$ 1.15MC$ -466.40MC$ 466.96MC$ 692.00K
EBITC$ -134.00KC$ 166.00KC$ 335.74MC$ -336.20MC$ -671.00K
EBITDAC$ -122.00KC$ 500.00KC$ -547.79MC$ 547.93MC$ -631.00K
Net Income Common StockholdersC$ -516.00KC$ -280.00KC$ 761.03MC$ -762.27MC$ -1.04M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 289.00KC$ 0.00C$ 8.00KC$ 0.00C$ 513.64K
Total AssetsC$ 36.95MC$ 32.97MC$ 30.90MC$ 29.65BC$ 29.56M
Total DebtC$ 13.68MC$ 14.31MC$ 15.74MC$ 13.88BC$ 10.79M
Net DebtC$ 13.39MC$ 14.31MC$ 15.73MC$ 13.88BC$ 10.28M
Total LiabilitiesC$ 17.48MC$ 18.30MC$ 22.25MC$ 19.90BC$ 19.02M
Stockholders EquityC$ 19.47MC$ 14.66MC$ 8.65MC$ 9.75BC$ 10.54M
Cash Flow-
Free Cash Flow---C$ -1.56B-
Operating Cash FlowC$ 1.80MC$ -1.91MC$ 6.10BC$ -1.50MC$ 4.69M
Investing Cash FlowC$ -2.55MC$ -689.00KC$ 1.67BC$ -1.29MC$ -97.00K
Financing Cash FlowC$ 1.36MC$ 2.56MC$ -7.74BC$ 2.25MC$ -5.55M
Currency in CAD

LSL Pharma Group Inc Earnings and Revenue History

LSL Pharma Group Inc Debt to Assets

LSL Pharma Group Inc Cash Flow

LSL Pharma Group Inc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis